Loss of MBNL Leads to Disruption of Developmentally Regulated Alternative Polyadenylation in RNA-Mediated Disease

Cited by (290)

Items 101–200 of 290

1. Global insights into alternative polyadenylation regulation
   Ranjan Batra, Mini Manchanda, Maurice S. Swanson · 2015 · RNA Biology
2. The CDK7 inhibitor THZ1 alters RNA polymerase dynamics at the 5′ and 3′ ends of genes
   Shilpa Sampathi, Pankaj Acharya, Yue Zhao, Jing Wang, Kristy R. Stengel, Qi Liu, Michael Robert Savona, Scott W. Hiebert · 2019 · Nucleic Acids Research
3. Alternative polyadenylation and RNA-binding proteins
   Ayşe Elif Erson-Bensan · 2016 · Journal of Molecular Endocrinology
4. Processing and transcriptome expansion at the mRNA 3′ end in health and disease: finding the right end
   Anton Ogorodnikov, Yulia Kargapolova, Sven Danckwardt · 2016 · Pflügers Archiv - European Journal of Physiology
5. Repeat RNA expansion disorders of the nervous system: post-transcriptional mechanisms and therapeutic strategies
   Joshua L. Schwartz, Krysten L. Jones, Gene Wei-Ming Yeo · 2020 · Critical Reviews in Biochemistry and Molecular Biology
6. Bioengineered in vitro 3D model of myotonic dystrophy type 1 human skeletal muscle
   Xiomara Fernández‐Garibay, María Alejandra Ortega, Estefanía Cerro-Herreros, Jordi Comelles, Elena Martínez, Ruben D. Artero, Juan M. Fernández‐Costa, Javier Ramón‐Azcón · 2021 · Biofabrication
7. Cooperation meets competition in microRNA-mediated DMPK transcript regulation
   Edyta Kościańska, Tomasz M. Witkos, Emilia Kozłowska, Marzena Wojciechowska, Włodzimierz J. Krzyżosiak · 2015 · Nucleic Acids Research
8. The polyG diseases: a new disease entity
   Tongling Liufu, Yilei Zheng, Jiaxi Yu, Yun Yuan, Zhaoxia Wang, Jianwen Deng, Daojun Hong · 2022 · Acta Neuropathologica Communications
9. TREND-DB—a transcriptome-wide atlas of the dynamic landscape of alternative polyadenylation
   Fédérico Marini, Denise Scherzinger, Sven Danckwardt · 2020 · Nucleic Acids Research
10. Regulation of Pre-mRNA Splicing: Indispensable Role of Post-Translational Modifications of Splicing Factors
    Miroslava Kretová, Tomas Selicky, Ingrid Čipáková, Luboš Čipák · 2023 · Life
11. Alternative polyadenylation and the stress response
    Jason Sadek, Amr Omer, Derek T. Hall, Kholoud Ashour, Imed‐Eddine Gallouzi · 2019 · Wiley Interdisciplinary Reviews - RNA
12. Repeat-associated RNA structure and aberrant splicing
    Melissa A. Hale, Nicholas Elwood Johnson, J. Andrew Berglund · 2019 · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms
13. Muscleblind‑like 1 destabilizes Snail mRNA and suppresses the metastasis of colorectal cancer cells via the Snail/E‑cadherin axis
    Liang Tang, Peng Zhao, Dalu Kong · 2019 · International Journal of Oncology
14. Review: Acetylation mechanisms and targeted therapies in cardiac fibrosis
    Weikang Liu, Qiuhuan Yuan, Shengchuan Cao, Guoying Wang, Xiangguo Liu, Yanan Xia, Yuan Bian, Feng Xu, Yuguo Chen · 2023 · Pharmacological Research
15. Antisense transcription of the myotonic dystrophy locus yields low-abundant RNAs with and without (CAG)n repeat
    Anke E. E. G. Gudde, Simon J. van Heeringen, Amanda I. De Oude, Ingeborg D.G. van Kessel, Joseph Estabrook, Eric T. Wang, Bé Wieringa, Derick G. Wansink · 2017 · RNA Biology
16. RBFOX2 is critical for maintaining alternative polyadenylation patterns and mitochondrial health in rat myoblasts
    Jun Cao, Sunil Kumar Verma, Elizabeth A. Jaworski, S. Mohan, Chloe K. Nagasawa, Kempaiah Rayavara, Amanda Sooter, Sierra N. Miller, Richard J. Holcomb, Mason J. Powell et al. · 2021 · Cell Reports
17. RNA FISH for detecting expanded repeats in human diseases
    Martyna Olga Urbanek-Trzeciak, Włodzimierz J. Krzyżosiak · 2015 · Methods
18. CRISPR gene editing in pluripotent stem cells reveals the function of MBNL proteins during humanin vitromyogenesis
    Antoine Mérien, Julie Tahraoui‐Bories, Michel Cailleret, Jean-Baptiste Dupont, Céline Leteur, Jérôme Polentes, Alexandre Carteron, Hélène Polvèche, Jean‐Paul Concordet, Christian Pinset et al. · 2021 · Human Molecular Genetics
19. Protein sequestration as a normal function of long noncoding RNAs and a pathogenic mechanism of RNAs containing nucleotide repeat expansions
    Ginny R. Morriss, Thomas A. Cooper · 2017 · Human Genetics
20. Pentamidine rescues contractility and rhythmicity in a Drosophila model of myotonic dystrophy heart dysfunction
    Mouli Chakraborty, Estela Selma-Soriano, Emile G. Magny, Juan Pablo Couso, Manuel Pérez‐Alonso, Nicolas Charlet‐Berguerand, Ruben D. Artero, Beatriz Llamusí · 2015 · Disease Models & Mechanisms
21. DSCAM-AS1-Driven Proliferation of Breast Cancer Cells Involves Regulation of Alternative Exon Splicing and 3′-End Usage
    Jamal Elhasnaoui, Valentina Miano, Giulio Ferrero, Elena Doria, Antonette E. Leon, Aline S.C. Fabricio, Laura Annaratone, Isabella Castellano, Anna Sapino, Michele De Bortoli · 2020 · Cancers
22. Identification of Targets of CUG-BP, Elav-Like Family Member 1 (CELF1) Regulation in Embryonic Heart Muscle
    Yotam N. Blech-Hermoni, Twishasri Dasgupta, Ryan J. Coram, Andrea N. Ladd · 2016 · PLoS ONE
23. Inflammation o'clock: interactions of circadian rhythms with inflammation‐induced skeletal muscle atrophy
    Francielly Morena da Silva, Karyn Ann Esser, Kevin A. Murach, Nicholas Perry Greene · 2023 · The Journal of Physiology
24. Activation and inhibition of nonsense-mediated mRNA decay control the abundance of alternative polyadenylation products
    Aparna Kishor, Sarah E Fritz, Nazmul Haque, Zhiyun Ge, Ilker Tunc, Wenjing Yang, Jun Zhu, J. Robert Hogg · 2020 · Nucleic Acids Research
25. La accesibilidad de los portales web de las universidades públicas andaluzas
    Luis Alejandro Casasola Balsells, Juan Carlos Guerra González, María Araceli Casasola Balsells, Vicente Antonio Pérez Chamorro · 2017 · Revista española de Documentación Científica
26. Mechanisms of repeat-associated non-AUG translation in neurological microsatellite expansion disorders
    Lydia M. Castelli, Wan-Ping Huang, Ya-Hui Lin, Kung‐Yao Chang, Guillaume M. Hautbergue · 2021 · Biochemical Society Transactions
27. Biomolecular condensates and disease pathogenesis
    Ke Ruan, Ge Bai, Yanshan Fang, Dan Li, Tingting Li, Xingguo Liu, Boxun Lu, Qing Lü, Zhou Songyang, Shuguo Sun et al. · 2024 · Science China Life Sciences
28. Cells of Matter—In Vitro Models for Myotonic Dystrophy
    Magdalena Matłoka, Arnaud F. Klein, Frédérique Rau, Denis Furling · 2018 · Frontiers in Neurology
29. Conserved functions of RNA-binding proteins in muscle
    Elena V. Nikonova, Shao-Yen Kao, Keshika Ravichandran, Anja Wittner, Maria Lynn Spletter · 2019 · The International Journal of Biochemistry & Cell Biology
30. FMRpolyG accumulates in FMR1 premutation granulosa cells
    Moran Friedman-Gohas, Shai Elazar Elizur, Olga Dratviman‐Storobinsky, Adva Aizer, Jigal Haas, Hila Raanani, Raoul Orvieto, Yoram Cohen · 2020 · Journal of Ovarian Research
31. Loss of MBNL1 induces RNA misprocessing in the thymus and peripheral blood
    Łukasz J. Sznajder, Marina M. Scotti, Jihae Shin, Katarzyna Taylor, Franjo Ivankovic, Curtis A. Nutter, Faaiq N. Aslam, S. H. Subramony, Laura P.W. Ranum, Maurice S. Swanson · 2020 · Nature Communications
32. Enhanced Delivery of Ligand-Conjugated Antisense Oligonucleotides (C16-HA-ASO) Targeting Dystrophia Myotonica Protein Kinase Transcripts for the Treatment of Myotonic Dystrophy Type 1
    Siham Ait Benichou, Dominic Jauvin, Thiéry De Serres‐Bérard, Frank Bennett, Frank Rigo, Geneviève Gourdon, Mohamed Boutjdir, Mohamed Chahine, Jack Puymirat · 2022 · Human Gene Therapy
33. Application of Antisense Conjugates for the Treatment of Myotonic Dystrophy Type 1
    Jessica Stoodley, Francisco Vallejo-Bedia, David Seoane-Miraz, Manuel Debasa‐Mouce, Matthew J. A. Wood, Miguel A. Varela · 2023 · International Journal of Molecular Sciences
34. Muscleblind-Like 1 and Muscleblind-Like 3 Depletion Synergistically Enhances Myotonia by Altering Clc-1 RNA Translation
    Jongkyu Choi, Kirkwood E. Personius, Marino DiFranco, Warunee Dansithong, Carl Yu, Saumya Srivastava, Donald M. Dixon, Darshan B. Bhatt, Lucio Comai, Julio L. Vergara et al. · 2015 · EBioMedicine
35. Targeting the Polyadenylation Signal of Pre-mRNA: A New Gene Silencing Approach for Facioscapulohumeral Dystrophy
    Anne-Charlotte Marsollier, Romain Joubert, Virginie Mariot, Julie Dumonceaux · 2018 · International Journal of Molecular Sciences
36. Proof of concept of peptide-linked blockmiR-induced MBNL functional rescue in myotonic dystrophy type 1 mouse model
    Sarah J. Overby, Estefanía Cerro-Herreros, Irene González-Martínez, Miguel A. Varela, David Seoane-Miraz, Yahya E. Jad, Richard Raz, Thorleif Møller, Manuel Pérez‐Alonso, Matthew J. A. Wood et al. · 2022 · Molecular Therapy — Nucleic Acids
37. MBNL1 overexpression is not sufficient to rescue the phenotypes in a mouse model of RNA toxicity
    Ramesh S. Yadava, Yun K Kim, Mahua Mandal, Karunasai Mahadevan, Jordan T. Gladman, Qing Cissy Yu, Mani S. Mahadevan · 2019 · Human Molecular Genetics
38. A CRISPR-Cas13a Based Strategy That Tracks and Degrades Toxic RNA in Myotonic Dystrophy Type 1
    Nan Zhang, Brittani Bewick, Guangbin Xia, Denis Furling, Tetsuo Ashizawa · 2020 · Frontiers in Genetics
39. Preclinical characterization of antagomiR-218 as a potential treatment for myotonic dystrophy
    Estefanía Cerro-Herreros, Irene González-Martínez, Nerea Moreno, Jorge Espinosa-Espinosa, Juan M. Fernández‐Costa, Anna Colom-Rodrigo, Sarah J. Overby, David Seoane-Miraz, Javier Poyatos‐García, Juan Jesus Vilchez et al. · 2021 · Molecular Therapy — Nucleic Acids
40. Regulation of the Alternative Neural Transcriptome by ELAV/Hu RNA Binding Proteins
    Wei Lü, Eric C. Lai · 2022 · Frontiers in Genetics
41. Mice lacking MBNL1 and MBNL2 exhibit sudden cardiac death and molecular signatures recapitulating myotonic dystrophy
    Kuang‐Yung Lee, Carol Seah, Ching Lin Li, Yu-Fu Chen, Chwen-Yu Chen, Ching-I Wu, Po-Cheng Liao, Yu‐Chiau Shyu, Hailey R. Olafson, Kendra McKee et al. · 2022 · Human Molecular Genetics
42. Dynamic landscape of alternative polyadenylation during retinal development
    Wenyan Hu, Shengguo Li, Ji Yeon Park, Sridhar Boppana, Ting Ni, Miaoxin Li, Jun Zhu, Bin Tian, Zhi Xie, Mengqing Xiang · 2016 · Cellular and Molecular Life Sciences
43. Muscleblind-like 2 controls the hypoxia response of cancer cells
    Sandra Elisabeth Fischer, Antonella Di Liddo, Katarzyna Taylor, Jamina Sofie Gerhardus, Krzysztof Sobczak, Kathi Zarnack, Julia E. Weigand · 2020 · RNA
44. Recovery in the Myogenic Program of Congenital Myotonic Dystrophy Myoblasts after Excision of the Expanded (CTG)n Repeat
    Laurène M. André, Remco T. P. van Cruchten, Marieke P. Willemse, Karel Bezstarosti, Jeroen Demmers, Ellen L. van Agtmaal, Derick G. Wansink, Bé Wieringa · 2019 · International Journal of Molecular Sciences
45. Myotonic dystrophy type 1: clinical diversity, molecular insights and therapeutic perspectives
    Lisa Rahm, Melissa A. Hale, Renée H.L. Raaijmakers, Alexandra Marrero Quiñones, Tejal Patki, Nicholas Elwood Johnson, Hans van Bokhoven, Karlien Mul · 2025 · Nature Reviews Neurology
46. Integrative Cell Type-Specific Multi-Omics Approaches Reveal Impaired Programs of Glial Cell Differentiation in Mouse Culture Models of DM1
    Anchel González‐Barriga, Louison Lallemant, Diana Mihaela Dincã, Sandra Bráz, Hélène Polvèche, Paul Magneron, Cédric Pionneau, Aline Huguet-Lachon, Jean‐Baptiste Claude, Cérina Chhuon et al. · 2021 · Frontiers in Cellular Neuroscience
47. Brain Pathogenesis and Potential Therapeutic Strategies in Myotonic Dystrophy Type 1
    Jie Liu, Zhen‐Ni Guo, Xiu‐Li Yan, Yi Yang, Shuo Huang · 2021 · Frontiers in Aging Neuroscience
48. Muscleblind-like proteins use modular domains to localize RNAs by riding kinesins and docking to membranes
    2023
49. RNA splicing during terminal erythropoiesis
    John G. Conboy · 2017 · Current Opinion in Hematology
50. Regulators of alternative polyadenylation operate at the transition from mitosis to meiosis
    Lingjuan Shan, Chan Wu, Di Chen, Lei Hou, Xin Li, Lixia Wang, Xiao Chu, Yifeng Hou, Zhaohui Wang · 2017 · Journal of genetics and genomics/Journal of Genetics and Genomics
51. RNA-binding Protein MBNL2 regulates Cancer Cell Metastasis through MiR-182-MBNL2-AKT Pathway
    Guanglan Lin, Jiao Li, Jin Lin Cai, Haowei Zhang, Qilei Xin, Ningchao Wang, Weidong Xie, Yaou Zhang, Naihan Xu · 2021 · Journal of Cancer
52. Expanded CCUG repeat RNA expression in Drosophila heart and muscle trigger Myotonic Dystrophy type 1-like phenotypes and activate autophagocytosis genes
    Estefanía Cerro-Herreros, Mouli Chakraborty, Manuel Pérez‐Alonso, Ruben D. Artero, Beatriz Llamusí · 2017 · Scientific Reports
53. Transcriptome Analysis in a Primary Human Muscle Cell Differentiation Model for Myotonic Dystrophy Type 1
    Vanessa Todorow, Stefan Hintze, Alastair R. W. Kerr, Andreas Hehr, Benedikt G. H. Schoser, Peter Meinke · 2021 · International Journal of Molecular Sciences
54. Trans-genetic effects of circular RNA expression quantitative trait loci and potential causal mechanisms in autism
    Te‐Lun Mai, Chia-Ying Chen, Yu‐Chen Chen, Tai-Wei Chiang, Trees‐Juen Chuang · 2022 · Molecular Psychiatry
55. Inhibition of cyclooxygenase-1 by nonsteroidal anti-inflammatory drugs demethylates MeR2 enhancer and promotes Mbnl1 transcription in myogenic cells
    Kun Huang, Akio Masuda, Guiying Chen, Samira Bushra, Masayoshi Kamon, Toshiyuki Araki, Masanobu Kinoshita, Bisei Ohkawara, Mikako Ito, Kinji Ohno · 2020 · Scientific Reports
56. Regulation of alternative splicing and polyadenylation in neurons
    Seungjae Lee, Joseph I Aubee, Eric C. Lai · 2023 · Life Science Alliance
57. An engineered RNA binding protein with improved splicing regulation
    Melissa A. Hale, Jared I. Richardson, Ryan C Day, Ona L. McConnell, Juan D. Arboleda, Eric T. Wang, J. Andrew Berglund · 2017 · Nucleic Acids Research
58. Molecular characterization of myotonic dystrophy fibroblast cell lines for use in small molecule screening
    Jana R. Jenquin, Alana O’Brien, Kiril Poukalov, Yidan Lu, Jesus A. Frias, Hannah K. Shorrock, Jared I. Richardson, Hormoz Mazdiyasni, Hongfen Yang, Robert W. Huigens et al. · 2022 · iScience
59. Alternative polyadenylation regulation in cardiac development and cardiovascular disease
    Jun Cao, Muge N. Kuyumcu‐Martinez · 2023 · Cardiovascular Research
60. Correction of Clcn1 alternative splicing reverses muscle fiber type transition in mice with myotonic dystrophy
    Ningyan Hu, Eunjoo Kim, Layal Antoury, Thurman M. Wheeler · 2023 · Nature Communications
61. miR-1/206 downregulates splicing factor Srsf9 to promote C2C12 differentiation
    Kristen K. Bjorkman, Massimo Buvoli, Emily K. Pugach, Michael M. Polmear, Leslie Anne Leinwand · 2019 · Skeletal Muscle
62. Implications of Poly(A) Tail Processing in Repeat Expansion Diseases
    Paweł Joachimiak, Adam Ciesiołka, Grzegorz Figura, Agnieszka Fiszer · 2022 · Cells
63. Conservation of context-dependent splicing activity in distant Muscleblind homologs
    Julia C. Oddo, Tanvi Saxena, Ona L. McConnell, J. Andrew Berglund, Eric T. Wang · 2016 · Nucleic Acids Research
64. Reversible cardiac disease features in an inducible CUG repeat RNA–expressing mouse model of myotonic dystrophy
    Ashish N. Rao, Hannah M. Campbell, Xiangnan Guan, Tarah A. Word, Xander H.T. Wehrens, Zheng Xia, Thomas A. Cooper · 2021 · JCI Insight
65. Distribution of alternative untranslated regions within the mRNA of the CELF1 splicing factor affects its expression
    Arkadiusz Kajdasz, Daria Niewiadomska, Michał Sekrecki, Krzysztof Sobczak · 2022 · Scientific Reports
66. The X-linked splicing regulator MBNL3 has been co-opted to restrict placental growth in eutherians
    Thomas Spruce, Mireya Plass, André Gohr, Debashish Ray, María Martínez de Lagrán, Gregor Rot, Ana Nóvoa, Demián Burguera, Jon Permanyer, Marta Miret-Cuesta et al. · 2022 · PLoS Biology
67. Peptide-conjugated antimiRs improve myotonic dystrophy type 1 phenotypes by promoting endogenous MBNL1 expression
    Irene González-Martínez, Estefanía Cerro-Herreros, Nerea Moreno, Andrea García-Rey, Jorge Espinosa-Espinosa, Marc Carrascosa-Sàez, Diego Piqueras‐Losilla, Andrey A. Arzumanov, David Seoane-Miraz, Yahya E. Jad et al. · 2023 · Molecular Therapy — Nucleic Acids
68. Defective Ribonucleoproteins, Mistakes in RNA Processing, and Diseases
    Mia K. Mihailovic, Angela Chen, Juan C. Gonzalez‐Rivera, Lydia M. Contreras · 2017 · Biochemistry
69. Faulty RNA splicing: consequences and therapeutic opportunities in brain and muscle disorders
    Vittoria Pagliarini, Piergiorgio La Rosa, Claudio Sette · 2017 · Human Genetics
70. Emerging roles of alternative cleavage and polyadenylation (APA) in human disease
    Prakash Dharmalingam, Rajasekaran Mahalingam, Hari Krishna Yalamanchili, Tingting Weng, Harry Karmouty‐Quintana, Ashrith Guha, Rajarajan A. Thandavarayan · 2021 · Journal of Cellular Physiology
71. scAPAatlas: an atlas of alternative polyadenylation across cell types in human and mouse
    Xiaoxiao Yang, Yang Tong, Gerui Liu, Jiapei Yuan, Yang Yang · 2021 · Nucleic Acids Research
72. Can Human Pluripotent Stem Cell-Derived Cardiomyocytes Advance Understanding of Muscular Dystrophies?
    Spandan Kalra, Federica Montanaro, Chris N. Denning · 2016 · Journal of Neuromuscular Diseases
73. Optical Mapping Approaches on Muscleblind‐Like Compound Knockout Mice for Understanding Mechanistic Insights Into Ventricular Arrhythmias in Myotonic Dystrophy
    Chung‐Chuan Chou, Po‐Cheng Chang, Yi‐Chia Wei, Kuang‐Yung Lee · 2017 · Journal of the American Heart Association
74. Calpain-2 Mediates MBNL2 Degradation and a Developmental RNA Processing Program in Neurodegeneration
    Lee‐Hsin Wang, Chien‐Yu Lin, Yu-Mei Lin, Luc Buée, Nicolas Sergeant, David L Blum, Yijuang Chern, Guey‐Shin Wang · 2022 · Journal of Neuroscience
75. Zebrafish mbnl mutants model physical and molecular phenotypes of myotonic dystrophy
    Melissa N. Hinman, Jared I. Richardson, Rose A. Sockol, Eliza D Aronson, Sarah J. Stednitz, Katrina N. Murray, J. Andrew Berglund, Karen J. Guillemin · 2021 · Disease Models & Mechanisms
76. Pro-inflammatory polarization and colorectal cancer modulate alternative and intronic polyadenylation in primary human macrophages
    Joana Wilton, Filipa Lopes de Mendonça, Isabel Pereira‐Castro, Michael Tellier, Takayuki Nojima, Ângela M. Costa, Jaime Freitas, Shona Murphy, María José Oliveira, Nicholas J. Proudfoot et al. · 2023 · Frontiers in Immunology
77. Multiplexed screening reveals how cancer-specific alternative polyadenylation shapes tumor growth in vivo
    Austin M. Gabel, Andrea E. Belleville, James D. Thomas, Siegen A. McKellar, Taylor R. Nicholas, Toshihiro Banjo, Edie I. Crosse, Robert K. Bradley · 2024 · Nature Communications
78. RNA structure probing to characterize RNA–protein interactions on low abundance pre-mRNA in living cells
    Jodi L. Bubenik, Melissa A. Hale, Ona L. McConnell, Eric T. Wang, Maurice S. Swanson, Robert C. Spitale, J. Andrew Berglund · 2020 · RNA
79. New Insights Into the Role of RNA-Binding Proteins in the Regulation of Heart Development
    Andrea N. Ladd · 2016 · International review of cytology
80. Functions of the Muscleblind-like protein family and their role in disease
    Hui Zhou, Jiachi Xu, Liusheng Pan · 2025 · Cell Communication and Signaling
81. Genome-Wide Analysis and Functional Characterization of the Polyadenylation Site in Pigs Using RNAseq Data
    Hongyang Wang, Rui Li, Xiang Zhou, Liyao Xue, Xuewen Xu, Bang Liu · 2016 · Scientific Reports
82. Biophysical mechanisms for QRS- and QTc-interval prolongation in mice with cardiac expression of expanded CUG-repeat RNA
    Kevin M. Tylock, David S. Auerbach, Zhen Zhi Tang, Charles A. Thornton, Robert T. Dirksen · 2020 · The Journal of General Physiology
83. MBNL1 regulates isoproterenol‐induced myocardial remodelling in vitro and in vivo
    Yao Xu, Chen Liang, Ying Luo, Tongcun Zhang · 2020 · Journal of Cellular and Molecular Medicine
84. Promoter-targeted small RNA duplexes increase MBNL1 transcription and mitigate myotonic dystrophy-associated spliceopathy
    Nikola Musiała, Patrycja Plewka, Adam Jasiok, Ewa Stępniak-Konieczna · 2025 · Nucleic Acids Research
85. MBNL splicing factors regulate the microtranscriptome of skeletal muscles
    Agnieszka Piasecka, Michał Wojciech Szcześniak, Michał Sekrecki, Arkadiusz Kajdasz, Łukasz J. Sznajder, Anna Baud, Krzysztof Sobczak · 2024 · Nucleic Acids Research
86. AntimiR treatment corrects myotonic dystrophy primary cell defects across several CTG repeat expansions with a dual mechanism of action
    Estefanía Cerro-Herreros, Judit Núñez‐Manchón, Neia Naldaiz‐Gastesi, Marc Carrascosa-Sàez, Andrea García-Rey, Diego Piqueras‐Losilla, Irene González-Martínez, Jorge Espinosa-Espinosa, Kevin Moreno, Javier Poyatos‐García et al. · 2024 · Science Advances
87. Towards development of a statistical framework to evaluate myotonic dystrophy type 1 mRNA biomarkers in the context of a clinical trial
    Adam Kurkiewicz, Anneli Cooper, Emily McIlwaine, Sarah A. Cumming, Berit Adam, Ralf Krahe, Jack Puymirat, Benedikt G. H. Schoser, Lubov Timchenko, Tetsuo Ashizawa et al. · 2020 · PLoS ONE
88. Alternative splicing regulation of membrane trafficking genes during myogenesis
    Emma R. Hinkle, Hannah J. Wiedner, Eduardo V. Torres, Micaela Jackson, Adam J. Black, R. Eric Blue, Sarah Elizabeth Harris, Bryan B. Guzmán, Gabrielle M. Gentile, Eunice Y. Lee et al. · 2022 · RNA
89. Mapping transcriptome‐wide protein‐RNA interactions to elucidate RNA regulatory programs
    Molly M. Hannigan, Leah L. Zagore, Donny D. Licatalosi · 2018 · Quantitative Biology
90. Disrupting the Molecular Pathway in Myotonic Dystrophy
    Xiaomeng Xing, Anjani Kumari, Jake Brown, J. David Brook · 2021 · International Journal of Molecular Sciences
91. Bioinformatics Tools for RNA-seq Gene and Isoform Quantification
    Chi Zhang, Baohong Zhang, Michael S. Vincent, Shanrong Zhao · 2016 · Journal of Next Generation Sequencing & Applications
92. Bruno 1/CELF regulates splicing and cytoskeleton dynamics to ensure correct sarcomere assembly in Drosophila flight muscles
    Elena V. Nikonova, Jenna DeCata, Marc Canela-Grimau, Christiane Barz, Alexandra Esser, Jessica Bouterwek, Akanksha Roy, Heidemarie Gensler, Martin Heß, Tobias Straub et al. · 2024 · PLoS Biology
93. The Estrogen Receptor α Signaling Pathway Controls Alternative Splicing in the Absence of Ligands in Breast Cancer Cells
    Jamal Elhasnaoui, Giulio Ferrero, Valentina Miano, Santina Cutrupi, Michele De Bortoli · 2021 · Cancers
94. Deciphering the Complex Molecular Pathogenesis of Myotonic Dystrophy Type 1 through Omics Studies
    Jorge Espinosa-Espinosa, Anchel González‐Barriga, A López, Ruben D. Artero · 2022 · International Journal of Molecular Sciences
95. RNA-Binding Proteins: A Role in Neurotoxicity?
    Andrea Ocharán-Mercado, Jaqueline Loaeza-Loaeza, Yaneth Castro-Coronel, Leonor C Acosta-Saavedra, L. C. Hernández-Kelly, Daniel Hernández-Sotelo, Arturo Ortega · 2023 · Neurotoxicity research
96. Muscleblind-like 1 is required for normal heart valve development in vivo
    Ryan J. Coram, Samantha J. Stillwagon, Anuradha Guggilam, Michael W. Jenkins, Maurice S. Swanson, Andrea N. Ladd · 2015 · BMC Developmental Biology
97. Trinucleotide-repeat expanded and normal DMPK transcripts contain unusually long poly(A) tails despite differential nuclear residence
    Anke E. E. G. Gudde, Ingeborg D.G. van Kessel, Laurène M. André, Bé Wieringa, Derick G. Wansink · 2017 · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms
98. Overlapping mechanisms of lncRNA and expanded microsatellite RNA
    Sara J. Johnson, Thomas A. Cooper · 2020 · Wiley Interdisciplinary Reviews - RNA
99. Loss of muscleblind splicing factor shortens Caenorhabditis elegans lifespan by reducing the activity of p38 MAPK/PMK-1 and transcription factors ATF-7 and Nrf/SKN-1
    Olli Matilainen, Ana Rita Salgado Ribeiro, Jens Verbeeren, Murat Çetinbaş, Heini Sood, Ruslan I. Sadreyev, Susana M. D. A. Garcia · 2021 · Genetics
100. Altered drug metabolism and increased susceptibility to fatty liver disease in a mouse model of myotonic dystrophy
     Zachary Dewald, Oluwafolajimi Adetoye Adesanya, Haneui Bae, Andrew S. Gupta, Jessica M. Derham, Ullas Valiya Chembazhi, Auinash Kalsotra · 2024 · Nature Communications